First Turn Management »

Arcellx shares owned by First Turn Management

Quarter-by-quarter ownership of Arcellx (ACLX) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Arcellx

Tip: Access up to 7 years of quarterly data

All positions including Arcellx held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcellx by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $18M 214k 83.51

More positions owned by First Turn Management

Nuvalent Inc-a (NUVL)
Argenx Se Sponsored Adr (ARGX)
Insmed Com Par $.01 (INSM)
Mirum Pharmaceuticals (MIRM)
Vaxcyte (PCVX)
Axsome Therapeutics (AXSM)
Syndax Pharmaceuticals (SNDX)
Ascendis Pharma A/s Sponsored Adr (ASND)
Natera (NTRA)
Intra Cellular Therapies (ITCI)
Crinetics Pharmaceuticals In (CRNX)
Transmedics Group (TMDX)
Arcellx Common Stock (ACLX)
Blueprint Medicines (BPMC)
Verona Pharma Sponsored Ads (VRNA)

View all positions for First Turn Management

Top funds holding Arcellx

BlackRock
Perceptive Advisors
Paradigm Biocapital Advisors
NEA Management Company
BlackRock
Sr One Capital Management
Vanguard Group
Henderson Group
State Street Corporation
T. Rowe Price Associates
RA Capital Management
Cormorant Asset Management
Suvretta Capital Management
T. Rowe Price Investment Management
Geode Capital Management

View all funds holding Arcellx